Difference between revisions of "Breast cancer BRCA1 & BRCA2 genetic testing"

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search
m (added link)
m (Warner-admin moved page Breast cancer BRCA1/BRCA2 genetic testing to Breast cancer BRCA1 & BRCA2 genetic testing without leaving a redirect: Reserved character)
 
(10 intermediate revisions by 3 users not shown)
Line 1: Line 1:
'''Use of this site is subject to you reading and agreeing with the terms set forth in the [[HemOnc.org_-_A_Hematology_Oncology_Wiki:General_disclaimer|disclaimer]].'''
+
<!--'''Use of this site is subject to you reading and agreeing with the terms set forth in the [[HemOnc.org_-_A_Hematology_Oncology_Wiki:General_disclaimer|disclaimer]]. If this is your first time visiting, we suggest you read the [[tutorial]].'''-->
  
 
=Criteria for BRCA1/BRCA2 genetic testing=
 
=Criteria for BRCA1/BRCA2 genetic testing=
Line 19: Line 19:
 
==References==
 
==References==
 
<references />
 
<references />
 +
 +
[[Category:Breast cancer pages]]
 +
[[Category:Disease-specific pages]]
 +
[[Category:General reference pages]]

Latest revision as of 16:38, 23 November 2019


Criteria for BRCA1/BRCA2 genetic testing

This is from a clinical trial protocol and is similar to, but not identical to, the NCCN breast cancer familiar risk assessment guidelines.[1] Additional resources can be found at the links below.[2][3]

  • Breast cancer diagnosed ≤45 years old
  • Diagnosed at age ≤50 years old with:
    • first, second, or third-degree blood relative with breast cancer diagnosis ≤50 years old
    • and/or epithelial ovarian or fallopian peritoneal cancer at any age
  • Diagnosed at age <60 years old with a triple negative breast cancer
  • Two breast primaries--that is, bilateral disease or two or more clearly separate ipsilateral primary tumors--when first breast cancer diagnosis occurred prior to age 50
  • Personal history of epithelial ovarian, fallopian tube, or primary peritoneal cancer
  • Diagnosed at any age with ≥2 first, second, or third-degree relatives with breast and/or epithelial ovarian, fallopian tube, or primary peritoneal cancer at any age
  • First or second-degree relative of anybody known to carry a harmful BRCA1 or BRCA2 mutation
  • Ashkenazi Jewish descent
  • Male breast cancer
  • First, second, or third-degree male relative with breast cancer

References